123 related articles for article (PubMed ID: 38040060)
1. Updated Trends in Cervical Cancer Brachytherapy Utilization and Disparities in the United States From 2004 to 2020.
Colson-Fearon D; Han K; Roumeliotis MB; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):154-162. PubMed ID: 38040060
[TBL] [Abstract][Full Text] [Related]
2. Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States: A Surveillance, Epidemiology, and End-Results Study.
Han K; Colson-Fearon D; Liu ZA; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):143-153. PubMed ID: 37951548
[TBL] [Abstract][Full Text] [Related]
3. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.
Gill BS; Lin JF; Krivak TC; Sukumvanich P; Laskey RA; Ross MS; Lesnock JL; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1083-90. PubMed ID: 25216857
[TBL] [Abstract][Full Text] [Related]
4. Declining brachytherapy utilization for cervical cancer patients - Have we reversed the trend?
Schad MD; Patel AK; Glaser SM; Balasubramani GK; Showalter TN; Beriwal S; Vargo JA
Gynecol Oncol; 2020 Mar; 156(3):583-590. PubMed ID: 31924333
[TBL] [Abstract][Full Text] [Related]
5. Disparities Among Cervical Cancer Patients Receiving Brachytherapy.
Bruce SF; Joshi TV; Chervoneva I; Yi M; Chatterjee-Paer S; Burton ER; Edelson MI; Sorosky JI; Shahin MS
Obstet Gynecol; 2019 Sep; 134(3):559-569. PubMed ID: 31403593
[TBL] [Abstract][Full Text] [Related]
6. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
Alimena S; Yang DD; Melamed A; Mahal BA; Worley MJ; Feldman S; Elias KM; Orio PF; Lee LJ; King M
Gynecol Oncol; 2019 Sep; 154(3):595-601. PubMed ID: 31292103
[TBL] [Abstract][Full Text] [Related]
8. Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer.
Korenaga TK; Yoshida EJ; Pierson W; Chang J; Ziogas A; Swanson ML; Chapman JS; Sinha S; Chen LM
Gynecol Oncol; 2022 Feb; 164(2):348-356. PubMed ID: 34865860
[TBL] [Abstract][Full Text] [Related]
9. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
10. Trends in the utilization of brachytherapy in cervical cancer in the United States.
Han K; Milosevic M; Fyles A; Pintilie M; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):111-9. PubMed ID: 23849695
[TBL] [Abstract][Full Text] [Related]
11. Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities.
Boyce-Fappiano D; Nguyen KA; Gjyshi O; Manzar G; Abana CO; Klopp AH; Kamrava M; Orio PF; Thaker NG; Mourtada F; Venkat P; Chang AJ
JCO Oncol Pract; 2021 Dec; 17(12):e1958-e1967. PubMed ID: 34550749
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of sociodemographic and baseline patient characteristic differences in cervical cancer patients treated with either external beam or brachytherapy boost.
Lu DJ; Atkins KM; Small W; Kamrava M
Brachytherapy; 2022; 21(1):22-28. PubMed ID: 34895839
[TBL] [Abstract][Full Text] [Related]
14. Identifying disparities in brachytherapy delivery for locally advanced cervical cancer.
Eakin A; Wairiri L; Stadtlander W; Bruegl A; Emerson J; Williamson C; Kahn J
Brachytherapy; 2023; 22(4):461-467. PubMed ID: 37015846
[TBL] [Abstract][Full Text] [Related]
15. Disparities in brachytherapy utilization in cervical cancer in the United States: A comprehensive literature review.
Kumar R; Sherwani Z; Lopez M; Vergalasova I; Zhang X; Eckroate B; Hollingsworth J; Girda E; Hathout L
Gynecol Oncol; 2023 Dec; 179():79-84. PubMed ID: 37944329
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
Ito K; Shimizuguchi T; Karasawa K
Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
[TBL] [Abstract][Full Text] [Related]
17. Computed Tomography-Planned High-Dose-Rate Brachytherapy for Treating Uterine Cervical Cancer.
Zolciak-Siwinska A; Gruszczynska E; Bijok M; Jonska-Gmyrek J; Dabkowski M; Staniaszek J; Michalski W; Kowalczyk A; Milanowska K
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):87-92. PubMed ID: 27375169
[TBL] [Abstract][Full Text] [Related]
18. High versus low-dose rate brachytherapy for cervical cancer.
Patankar SS; Tergas AI; Deutsch I; Burke WM; Hou JY; Ananth CV; Huang Y; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2015 Mar; 136(3):534-41. PubMed ID: 25575481
[TBL] [Abstract][Full Text] [Related]
19. Racial Disparities in Brachytherapy Treatment among Women with Cervical and Endometrial Cancer in the United States.
Taparra K; Ing BI; Ewongwo A; Vo JB; Shing JZ; Gimmen MY; Keli'i KMK; Uilelea J; Pollom E; Kidd E
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174037
[TBL] [Abstract][Full Text] [Related]
20. Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California.
Mayadev J; Klapheke A; Yashar C; Hsu IC; Kamrava M; Mundt AJ; Mell LK; Einck J; Benedict S; Valicenti R; Cress R
Gynecol Oncol; 2018 Jul; 150(1):73-78. PubMed ID: 29709291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
